Literature DB >> 16982553

Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing response.

Michael R Horsman1, Thomas Nielsen, Leif Østergaard, Jens Overgaard.   

Abstract

This study was designed to demonstrate a differential tumour response to radiation given as a large single dose or fractionated, and to investigate the postulated role of the tumour vasculature as a target for this difference. A C3H mammary carcinoma grown in the right rear foot of female CDF1 mice was used when at 200 mm3. Radiation (240 kV x-rays) was given locally to the tumour bearing foot either as 1 x 20 Gy or 10 x 2 Gy (2 fractions/day). Tumour response was assessed by calculating tumour growth time (TGT; time to grow to 3 times treatment volume). Vascular effects were monitored by performing dynamic contrast enhanced-magnetic resonance imaging using a 3-Tesla magnet and the contrast agent gadolinium (Gd)-DTPA. The endpoint was the initial area under the concentration curve (IAUC) following Gd-DTPA. The mean (+/-1 S.E.) TGT for control mice was 4.0 days (+/-0.2). This was significantly (Student's t-test; p < 0.05) increased to 12.9 (+/-0.6) and 19.8 (+/-0.7) days, by 10 x 2 and 1 x 20 Gy, respectively. The mean (+/-1 S.E.) of the median IAUC values for control tumours was 8.4 mMs (+/-0.5). This was non-significantly increased to 9.4 mMs (+/-0.4) 6-hours after 1 x 20 Gy, but then significantly decreased to a nadir of 6.8 mMs (+/-0.5) after 48-hours. IAUC recovered at longer time intervals. With 10 x 2 Gy, IAUC significantly decreased during irradiation, reaching 6.7 (+/-0.3) and 5.6 (+/-0.3) mMs at the mid-point and end of the irradiation period, respectively. IAUC recovered 24-hours after irradiating before significantly decreasing to 4.4 mMs (+/-0.3) at 48-hours. Our results confirm that radiation given in a large single dose is superior to the same dose given in a more conventional fractionated schedule, but vascular-mediated effects did not account for this difference in radiation sensitivity.

Entities:  

Mesh:

Year:  2006        PMID: 16982553     DOI: 10.1080/02841860600900068

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  7 in total

1.  Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer.

Authors:  Kathrine Røe; Lars Tg Mikalsen; Albert J van der Kogel; Johan Bussink; Heidi Lyng; Anne H Ree; Laure Marignol; Dag R Olsen
Journal:  Radiat Oncol       Date:  2012-05-23       Impact factor: 3.481

2.  Differential response to ablative ionizing radiation in genetically distinct non-small cell lung cancer cells.

Authors:  Ayman Oweida; Zeinab Sharifi; Hani Halabi; Yaoxian Xu; Siham Sabri; Bassam Abdulkarim
Journal:  Cancer Biol Ther       Date:  2016-04-02       Impact factor: 4.742

3.  Ablative versus fractionated radiation therapy: a controversial role in cancer invasion and metastasis.

Authors:  A Oweida; B Abdulkarim
Journal:  Oncogene       Date:  2016-04-25       Impact factor: 9.867

4.  Acute Temporal Changes of MRI-Tracked Tumor Vascular Parameters after Combined Anti-angiogenic and Radiation Treatments in a Rat Glioma Model: Identifying Signatures of Synergism.

Authors:  Rasha Elmghirbi; Tavarekere N Nagaraja; Stephen L Brown; Swayamprava Panda; Madhava P Aryal; Kelly A Keenan; Hassan Bagher-Ebadian; Glauber Cabral; James R Ewing
Journal:  Radiat Res       Date:  2016-12-21       Impact factor: 2.841

5.  Dynamic contrast-enhanced and diffusion-weighted MRI for early detection of tumoral changes in single-dose and fractionated radiotherapy: evaluation in a rat rhabdomyosarcoma model.

Authors:  F De Keyzer; V Vandecaveye; H Thoeny; F Chen; Y Ni; G Marchal; R Hermans; S Nuyts; W Landuyt; H Bosmans
Journal:  Eur Radiol       Date:  2009-06-06       Impact factor: 5.315

Review 6.  Neovascularization after irradiation: what is the source of newly formed vessels in recurring tumors?

Authors:  Sergey V Kozin; Dan G Duda; Lance L Munn; Rakesh K Jain
Journal:  J Natl Cancer Inst       Date:  2012-05-09       Impact factor: 13.506

7.  Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments.

Authors:  Thomas Nielsen; Thomas Wittenborn; Michael R Horsman
Journal:  Pharmaceutics       Date:  2012-11-07       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.